Top

Published in:

01-03-2023 | Human Immunodeficiency Virus | Short Communication

HIV viremia contributes to neurocognitive impairments in persons who use cocaine

Authors: Kareem Al-Khalil, Sheri L. Towe, Taylor P. Ikner, Christina S. Meade

Published in: Journal of NeuroVirology | Issue 3/2023

Abstract

Persons with HIV (PWH) who use illicit drugs are at elevated risk for neurocognitive impairment (NCI). This study investigated the effects of HIV disease and HIV viremia on NCI among adults who use cocaine. PWH who were not virologically suppressed showed greater global deficits compared to participants with HIV viral suppression and HIV-negative participants, but no differences emerged between the latter two groups. These findings highlight the adverse effects of poorly controlled HIV disease on NCI, beyond the independent effects of cocaine on cognition, and underscore the importance of strengthening the HIV care continuum for persons who use cocaine.

Anand P, Springer SA, Copenhaver MM, Altice FL (2010) Neurocognitive impairment and HIV risk factors: a reciprocal relationship. AIDS Behav 14(6):1213–1226CrossRefPubMedPubMedCentral

Arnsten JH, Demas PA, Grant RW, Gourevitch MN, Farzadegran H, Howard AA, Schoenbaum EE (2002) Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med 17(5):377–381CrossRefPubMedPubMedCentral

Baum MK, Rafie C, Lai S, Sales S, Page B, Campa A (2009) Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users. J Acquir Immune Defic Syndr 50:93–99CrossRefPubMed

Benton A, Hamsher K, Sivan A (1983) Multilingual aphasia examination, 3rd edn. AJA Associates, Iowa City, IA

Boucoiran I, Albert A, Tulloch K, Wagner EC, Pick N, van Schalkwyk J, Harrigan PR, Money D (2017) Human immunodeficiency virus viral load rebound near delivery in previously suppressed, combination antiretroviral therapy-treated pregnant women. Obstet Gynecol 130(3):497–501. https://doi.org/10.1097/AOG.0000000000002133CrossRefPubMed

Brandt J, Benedict RHB (2001) Hopkins Verbal Learning Test — revised professional manual. Psychological Assessment Resources Inc, Lutz, FL

Burch AE, Rash CJ, Petry NM (2017) Cocaine-using substance abuse treatment patients with and without HIV respond well to contingency management treatment. J Subst Abuse Treat 77:21–25. https://doi.org/10.1016/j.jsat.2017.03.001CrossRefPubMedPubMedCentral

Cai Y, Yang L, Callen S, Buch S (2016) Multiple faceted roles of cocaine in potentiation of HAND. Curr HIV Res 14(5):412–416. https://doi.org/10.2174/1570162x14666160324125158CrossRefPubMed

Cattie JE, Doyle K, Weber E, Grant I, Woods SP (2012) Planning deficits in HIV-associated neurocognitive disorders: component processes, cognitive correlates, and implications for everyday functioning. J Clin Exp Neuropsychol 34(9):906–918CrossRefPubMedPubMedCentral

Centers for Disease Control and Prevention (2020) Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2018. HIV Surveillance Supplemental Report, 25(2). http://www.cdc.gov/hiv/library/reports/hiv-surveillance.html. Accessed Sept 2021

Cheever LW (2007) Engaging HIV-infected patients in care: their lives depend on it. Clin Infect Dis 44:1500–1502CrossRefPubMed

Chilunda V, Calderon TM, Martinez-Aguado P, Berman JW (2019) The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era. Brain Res 1724:146426. https://doi.org/10.1016/j.brainres.2019.146426CrossRefPubMedPubMedCentral

Cisneros IE, Erdenizmenli M, Cunningham KA, Paessler S, Dineley KT (2018) Cocaine evokes a profile of oxidative stress and impacts innate antiviral response pathways in astrocytes. Neuropharmacology 135:431–443. https://doi.org/10.1016/j.neuropharm.2018.03.019CrossRefPubMedPubMedCentral

Diehr MC, Cherner M, Wolfson TJ, Miller SW, Grant I, Heaton RK (2003) The 50 and 100 item short forms of the Paced Auditory Serial Addition Task (PASAT): demographically corrected norms and comparisons with the full PASAT in normal and clinical samples. J Clin Exp Neuropsychol 25:571–585. https://doi.org/10.1076/jcen.25.4.571.13876CrossRefPubMed

Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW (2008) A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry 165:179–187CrossRefPubMed

Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP (2019) Ending the HIV Epidemic: a plan for the United States. JAMA 321(9):844–845CrossRefPubMed

First MB, Williams JBW, Karg RS, Spitzer RL (2015) Structured clinical interview for DSM-5—Research Version (SCID-5 for DSM-5, Research Version; SCID-5-RV). Arlington, VA: American Psychiatric Association

Foster S, LeFauve C, Kresky-Wolff M, Rickards L (2010) Services and supports for individuals with co-occurring disorders and long-term homelessness. J Behav Health Serv Res 37(2):239–251CrossRefPubMed

Gardner EM, McLees MP, Steiner JF, Del Rio C, Burman WJ (2011) The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 52:793–800. https://doi.org/10.1093/cid/ciq243CrossRefPubMedPubMedCentral

Garofalo R, Kuhns LM, Hotton A, Johnson A, Muldoon A, Rice D (2016) A randomized controlled trial of personalized text message reminders to promote medication adherence among HIV-positive adolescents and young adults. AIDS Behav 20(5):1049–1059CrossRefPubMedPubMedCentral

Gates TM, Cysique LA (2016) The chronicity of HIV infection should drive the research strategy of neuroHIV treatment studies: a critical review. Central Nerv Syst Drugs 30(1):53–69

Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR (2004) Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials 5(2):74–79CrossRefPubMed

Golden CJ (1978) Stroop Color and Word Test. Stoelting, Chicago, IL

Gott C, Gates T, Dermody N, Brew BJ, Cysique LA (2017) Cognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activity. PLoS ONE 12(3):e0171887CrossRefPubMedPubMedCentral

Gwadz M, de Guzman R, Freeman R, Kutnick A, Silverman E, Leonard NR, Ritchie AS, Munoz-Plaza C, Salomon D, Wolfe H, Hilliard C, Cleland CM, Honig S (2016) Exploring how substance use impedes engagement along the HIV care continuum: a qualitative study. Front Public Health 4:62CrossRefPubMedPubMedCentral

Heaton RK, Franklin DR Jr, Deutsch R, Letendre S, Ellis RJ, Casaletto K, Marquine M, Woods S, Vaida F, Atkinson J, Marcotte T, McCutchan J, Collier A, Marra C, Clifford D, Gelman B, Sacktor N, Morgello S, Simpson D, Abransom I, Gamst A, Fennema-Notestine C, Smith D, Grant I (2015) Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study. Clin Infect Dis 60(3):473–480CrossRefPubMed

Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, Grant I (2004) The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 10(3):317–331CrossRefPubMed

Klove H (1963) Grooved Pegboard. Lafayette Instruments, Lafayette, IN

Laverick R, Haddow L, Daskalopoulou M, Lampe F, Gilson R, Speakman A, Rodger A (2017) Self-reported decline in everyday function, cognitive symptoms, and cognitive function in people with HIV. J Acquir Immune Defic Syndr 76(3):e74–e83CrossRefPubMed

Lentz MR, Kim WK, Kim H, Soulas C, Lee V, Venna N, Halpern EF, Rosenberg ES, Williams K, González RG (2011) Alterations in brain metabolism during the first year of HIV infection. J Neurovirol 17(3):220–229. https://doi.org/10.1007/s13365-011-0030-9CrossRefPubMedPubMedCentral

Lucas GM, Gebo KA, Chaisson RE, Moore RD (2002) Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS 16(5):767–774CrossRefPubMed

McLellan AT, Alterman AI, Cacciola J, Metzger D, O’Brien CP (1992) A new measure of substance abuse treatment. Initial studies of the treatment services review. J Nerv Ment Dis 180(2):101–110

Meade CS, Towe SL, Skalski LM, Robertson KR (2015) Independent effects of HIV infection and cocaine dependence on neurocognitive impairment in a community sample living in the southern United States. Drug Alcohol Depend 149:128–135CrossRefPubMedPubMedCentral

Metsch LR, Feaster DJ, Gooden L, Matheson T, Stitzer M, Das M, Jain MK, Rodriguez AE, Armstrong WS, Lucas GM, Nijhawan AE, Drainoni ML, Herrera P, Vergara-Rodriguez P, Jacobson JM, Mugavero MJ, Sullivan M, Daar ES, McMahon DK, Ferris DC, del Rio C (2016) Effect of patient navigation with or without financial incentives on viral suppression among hospitalized patients with HIV infection and substance use: a randomized clinical trial. JAMA 316(2):156–170. https://doi.org/10.1001/jama.2016.8914CrossRefPubMedPubMedCentral

Pan Y, Metsch LR, Gooden LK, Philbin MM, Daar ES, Douaihy A, Jacobs P, Del Rio C, Rodriguez AE, Feaster DJ (2019) Viral suppression and HIV transmission behaviors among hospitalized patients living with HIV. Int J STD AIDS 30(9):891–901. https://doi.org/10.1177/0956462419846726CrossRefPubMedPubMedCentral

Parsons JT, Starks TJ, Millar BM, Boonrai K, Marcotte D (2014) Patterns of substance use among HIV-positive adults over 50: implications for treatment and medication adherence. Drug Alcohol Depend 139:33–40CrossRefPubMedPubMedCentral

Phillips J (2020) What you need to know about the 6 EHE indicators: The AHEAD Dashboard. What You Need to Know About the 6 EHE Indicators: The AHEAD Dashboard | HIV.gov

Potvin S, Stavro K, Rizkallah E, Pelletier J (2014) Cocaine and cognition: a systematic quantitative review. J Addict Med 8(5):368–376CrossRefPubMed

Priester MA, Browne T, Iachini A, Clone S, DeHart D, Seay KD (2016) Treatment access barriers and disparities among individuals with co-occurring mental health and substance use disorders: an integrative literature review. J Subst Abuse Treat 61:47–59CrossRefPubMed

Rasbach DA, Desruisseau AJ, Kipp AM, Stinnette S, Kheshti A, Shepherd BE, Qian HZ (2013) Active cocaine use is associated with lack of HIV-1 virologic suppression independent of nonadherence to antiretroviral therapy: use of a rapid screening tool during routine clinic visits. AIDS Care 25(1):109–117CrossRefPubMed

Reger M, Welsh R, Razani J, Martin DJ, Boone KB (2002) A meta-analysis of the neuropsychological sequelae of HIV infection. J Int Neuropsychol Soc JINS 8(3):410–424. https://doi.org/10.1017/s1355617702813212CrossRef

Reitan RM, Wolfson D (1993) The Halstead-Reitan Neuropsychological Test Battery: theory and clinical interpretation, 2nd edn. Neuropsycholgy Press, Tucson, AZ

Robinson SM, Sobell LC, Sobell MB, Leo GI (2014) Reliability of the timeline followback for cocaine, cannabis, and cigarette use. Psychol Addict Behav 28(1):154–162CrossRefPubMed

Saylor D, Dickens AM, Sacktor N, Haughey N, Slusher B, Pletnikov M, McArthur JC (2016) HIV-associated neurocognitive disorder - pathogenesis and prospects for treatment. Nat Rev Neurol 12(5):309CrossRefPubMedPubMedCentral

Shiau S, Arpadi SM, Yin MT, Martins SS (2017) Patterns of drug use and HIV infection among adults in a nationally representative sample. Addict Behav 68:39–44CrossRefPubMedPubMedCentral

Sobell, LC, Sobell MB (1992) Timeline follow-back: a technique for assessing self-reported ethanol consumption. In J. Allen R. Z. Litten (Eds.), Measuring alcohol consumption: psychosocial and biological methods (pp. 41–72). Totowa, NJ: Humana Press

Spronk DB, van Wel JHP, Ramaekers JG, Verkes RJ (2013) Characterizing the cognitive effects of cocaine: a comprehensive review. Neurosci Biobehav Rev 37(8):1838–1859CrossRefPubMed

Stern RA, White T (2009) NAB Digits Forward/Digits Backward Test: professional manual. Psychological Assessment Resources, Inc., Lutz, FL

Stitzer M, Matheson T, Cunningham C, Sorensen JL, Feaster DJ, Gooden L, Hammond AS, Fitzsimons H, Metsch LR (2017) Enhancing patient navigation to improve intervention session attendance and viral load suppression of persons with HIV and substance use: a secondary post hoc analysis of the Project HOPE study. Addict Sci Clin Pract 12(1):16. https://doi.org/10.1186/s13722-017-0081-1CrossRefPubMedPubMedCentral

Tate JP, Sterne JAC, Justice AC; Veterans Aging Cohort Study (VACS) and the Antiretroviral Therapy Cohort Collaboration (ART-CC) (2019) Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals. AIDS 33:903–912. https://doi.org/10.1097/QAD.0000000000002140CrossRefPubMed

Tolson C, Richey LE, Zhao Y, Korte JE, Brady K, Haynes L, Meissner EG (2018) Association of substance use with hospitalization and virologic suppression in a southern academic HIV clinic. Am J Med Sci 355(6):553–558CrossRefPubMedPubMedCentral

Wechsberg WM, van der Horst C, Ndirangu J, Doherty IA, Kline T, Browne FA, Belus JM, Nance R, Zule WA (2017) Seek, test, treat: substance-using women in the HIV treatment cascade in South Africa. Addict Sci Clin Pract 12(1):12. https://doi.org/10.1186/s13722-017-0077-xCrossRefPubMedPubMedCentral

Wilkinson GS, Robertson GJ (2006) Wide Range Achievement Test–4 (WRAT-4). Lutz, FL: Psychol Assess Resourc

Zayyad Z, Spudich S (2015) Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND). Curr HIV/AIDS Rep 12(1):16–24. https://doi.org/10.1007/s11904-014-0255-3CrossRefPubMedPubMedCentral

Title: HIV viremia contributes to neurocognitive impairments in persons who use cocaine
Authors: Kareem Al-Khalil
Sheri L. Towe
Taylor P. Ikner
Christina S. Meade
Publication date: 01-03-2023
Publisher: Springer International Publishing
Keyword: Human Immunodeficiency Virus
Published in: Journal of NeuroVirology / Issue 3/2023
Print ISSN: 1355-0284
Electronic ISSN: 1538-2443
DOI: https://doi.org/10.1007/s13365-022-01100-4

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

HIV viremia contributes to neurocognitive impairments in persons who use cocaine

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2023

Single nucleotide polymorphisms in aquaporin-4 associate with cognitive impairment status in people with HIV

Epileptic seizures associated with progressive multifocal leukoencephalopathy in HIV-infected patients in Korea

Expression in skin biopsies supports genetic evidence linking CAMKK2, P2X7R and P2X4R with HIV-associated sensory neuropathy

Persistent accelerated epigenetic ageing in a longitudinal cohort of vertically infected HIV-positive adolescents

Meningitis associated with HHV-7 in an Iranian immunocompetent adolescent girl

Multi-functional auto-fluorescent nanogels for theranostics